P456: LEUKEMOGENESIS BY AML-SPECIFIC DRIVER MUTATIONS WITHIN DNMT3A, IDH2 AND NPM1

• Ecmel Mehmetbeyoglu,
• Claudia Chiriches,
• Imran Shair Mohammed,
• Beyza Nur Onat,
• Kadir Yaray,
• Oguz Galip Yildiz,
• Serpil Taheri,
• Martin Ruthardt

Affiliations

Ecmel Mehmetbeyoglu

1 Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom

Claudia Chiriches

1 Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom

Imran Shair Mohammed

2 ERKAM-Clinical Engineering Research and Application Centre, Erciyes University, Kayseri, Turkey

Beyza Nur Onat

3 Betul Ziya Eren Genome and Stem Cell Centre, Erciyes University, Kayseri, Turkey

Kadir Yaray

4 Department of Radiation Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey

Oguz Galip Yildiz

4 Department of Radiation Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey

Serpil Taheri

3 Betul Ziya Eren Genome and Stem Cell Centre, Erciyes University, Kayseri, Turkey

Martin Ruthardt

1 Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom